SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of ...

Arcturus Therapeutics Holdings Inc. ARCT announced that the FDA has granted a Fast Track designation to its self-amplifying mRNA (sa-mRNA) vaccine candidate, ARCT-2304, for active immunization to ...

Arcturus Therapeutics (ARCT) announced that the FDA has granted fast track designation for the self-amplifying mRNA vaccine candidate, ARCT-2304, designed for active immunization to protect ...

Guggenheim analyst Seamus Fernandez lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $45 from $71 and keeps a Buy rating on the shares. Although flat year-over-year sales in ...

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate. Arcturus on Thursday said the designation ...

SAN DIEGO - Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a biotechnology firm specializing in mRNA medicines with a market capitalization of $266 million, announced today that the U.S. Food and ...

The two brightest nighttime stars available in the Minnesota and Wisconsin sky are Sirius and Arcturus. April is the only month of the year we can enjoy both of them at the same time in the early ...

The two brightest nighttime stars visible in the Pottsville sky are Sirius and Arcturus. April is the only month of the year when we can enjoy both of them at the same time in the early evening ...

Arcturus Therapeutics Holdings Inc is a biotechnology firm based in San Diego, California, specializing in the development of innovative mRNA medicines and vaccines. With a focus on addressing ...

About Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious ...